Wells Fargo & Company Anixa Biosciences Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Wells Fargo & Company holds 8,500 shares of ANIX stock, worth $28,560. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,500

Previous 8,500 -0.0%

Holding current value

$28,560

Previous $18,000 44.44%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.21 - $3.35 $17,131 - $25,969	7,752 Added 1036.36%	8,500 $18,000
Q1 2024 May 10, 2024	BUY	$3.08 - $5.02 $27 - $45	9 Added 1.22%	748 $2,000
Q4 2023 Feb 09, 2024	BUY	$2.85 - $4.19 $37 - $54	13 Added 1.79%	739 $2,000
Q3 2023 Nov 13, 2023	BUY	$2.97 - $3.87 $8 - $11	3 Added 0.41%	726 $2,000
Q2 2023 Aug 15, 2023	BUY	$3.0 - $5.97 $27 - $53	9 Added 1.26%	723 $2,000
Q1 2023 May 12, 2023	SELL	$3.86 - $5.0 $3,840 - $4,975	-995 Reduced 58.22%	714 $3,000
Q4 2022 Feb 13, 2023	BUY	$3.78 - $5.81 $3,806 - $5,850	1,007 Added 143.45%	1,709 $7,000
Q2 2022 Aug 12, 2022	BUY	$2.55 - $4.1 $43 - $69	17 Added 2.48%	702 $3,000
Q1 2022 May 16, 2022	BUY	$2.5 - $3.42 $2 - $3	1 Added 0.15%	685 $2,000
Q4 2021 Feb 14, 2022	SELL	$2.88 - $5.5 $15,842 - $30,255	-5,501 Reduced 88.94%	684 $2,000
Q3 2021 Nov 15, 2021	SELL	$3.57 - $5.6 $17 - $28	-5 Reduced 0.08%	6,185 $30,000
Q2 2021 Aug 16, 2021	BUY	$3.46 - $4.92 $107 - $152	31 Added 0.5%	6,190 $24,000
Q1 2021 May 13, 2021	BUY	$3.27 - $7.14 $16,392 - $35,792	5,013 Added 437.43%	6,159 $29,000
Q4 2020 Feb 09, 2021	SELL	$1.94 - $3.19 $11,717 - $19,267	-6,040 Reduced 84.05%	1,146 $3,000
Q3 2020 Nov 05, 2020	SELL	$1.79 - $3.3 $1,392 - $2,567	-778 Reduced 9.77%	7,186 $17,000
Q2 2020 Aug 13, 2020	SELL	$1.53 - $3.06 $182 - $364	-119 Reduced 1.47%	7,964 $24,000
Q1 2020 May 14, 2020	BUY	$1.35 - $4.06 $10,912 - $32,816	8,083 New	8,083 $13,000

Others Institutions Holding ANIX

# of Institutions

Shares Held

5.56M

Call Options Held

21K

Put Options Held

6.7K

View Full List

About Anixa Biosciences Inc

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $103M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

More about ANIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Anixa Biosciences Inc Transaction History